Petco Health and Wellness Company Inc WOOF.OQ WOOF.O is expected to show a fall in quarterly revenue when it reports results on March 26 for the period ending January 31 2025
The San Diego California-based company is expected to report a 6.8% decrease in revenue to $1.561 billion from $1.67 billion a year ago, according to the mean estimate from 10 analysts, based on LSEG data.The company's guidance on December 5 2024, for the period ended January 31, was for revenue of $1.550 billion.
LSEG's mean analyst estimate for Petco Health and Wellness Company Inc is for earnings of 1 cent per share. The company's EPS guidance on December 5 2024, for the period ended January 31, was between $0.00 and $0.02
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 8 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Petco Health and Wellness Company Inc is $4.50, above its last closing price of $2.44.
The company's guidance on December 5 2024 for the period ended January 31 was for Earnings before Interest, Taxes, Depreciation and Amortization of between USD1.55 billion and USD95 million.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Oct. 31 2024 | -0.04 | -0.04 | -0.02 | Beat | 46.5 |
Jul. 31 2024 | -0.02 | -0.02 | -0.02 | Met | 13.6 |
Apr. 30 2024 | -0.07 | -0.07 | -0.04 | Beat | 40 |
Jan. 31 2024 | 0.02 | 0.02 | 0.02 | Met | 31.5 |
Oct. 31 2023 | 0.02 | 0.02 | -0.05 | Missed | -350 |
Jul. 31 2023 | 0.06 | 0.06 | 0.06 | Met | 6.4 |
Apr. 30 2023 | 0.05 | 0.05 | 0.06 | Beat | 21.9 |
Jan. 31 2023 | 0.24 | 0.24 | 0.23 | Missed | -4.3 |
This summary was machine generated March 24 at 20:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.